Abnormal blink reflex studies in a patient with supraorbital neuralgia.
A 44-year-old female with gabapentin-responsive supraorbital neuralgia is presented. She had pre- and post-treatment nociceptive-specific blink reflexes carried out which tracked the good clinical outcome from treatment. The results of the electrophysiological testing imply some central component to the pathophysiology of supra-orbital neuralgia.
Cohen
A S
AS
Headache Group, Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UK.
Gantenbein
A R
AR
Goadsby
P J
PJ
D000328:Adult; D000588:Amines / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001767:Blinking; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D005260:Female; D000077206:Gabapentin; D006801:Humans; D009288:Naproxen / Q000627:therapeutic use; D009437:Neuralgia / Q000175:diagnosis* / Q000188:drug therapy*; D009915:Orbit / Q000294:innervation*; D012021:Reflex, Abnormal; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use
D000588:Amines; D000700:Analgesics; D000894:Anti-Inflammatory Agents, Non-Steroidal; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D009288:Naproxen; D000077206:Gabapentin